Why buy Indian generic drugs? Are they really just cheaper?
Share
The phenomenon of buying Indian generic drugs in China has attracted widespread attention in recent years. Although China's pharmaceutical market is developing rapidly, a large number of patients still choose to buy Indian generic drugs. Here are several main reasons:
Price advantage
The prices of Indian generic drugs are usually much lower than the original drugs and domestic drugs on the Chinese market. India is one of the world's largest producers of generic drugs, and its pharmaceutical industry has economies of scale and lower production costs. For example, the price of some targeted drugs for treating cancer in India is only one-fifth of that in China or even lower. For many patients with limited economic conditions, price is an important factor in determining drug selection. The low prices of Indian generic drugs enable patients to receive high-quality treatment at a lower cost.
Drug quality
Indian generic drugs enjoy a high reputation in the international market. Many Indian pharmaceutical companies have strict production standards and have obtained certification from international authoritative organizations including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The generic drugs produced by these pharmaceutical companies are no different from the original drugs in terms of efficacy and safety, meet international standards, and ensure the quality of the drugs.
Supply and demand
There are drug shortages and supply-demand contradictions in China's pharmaceutical market, especially in the treatment of some rare and chronic diseases. Some imported drugs are expensive and in short supply, while domestic drugs cannot fully meet market demand. Indian generic drugs fill this gap with their rich variety and sufficient supply, providing patients with more treatment options.
Policy environment
Although the Chinese government has vigorously promoted medical reform and improved drug accessibility in recent years, the drug approval process is relatively long and the speed at which new drugs enter the market is slow. In addition, the patent protection policy has kept the prices of some original research drugs high and restricted the listing of generic drugs. In contrast, India's generic drug policy is relatively relaxed, allowing pharmaceutical companies to quickly produce generic drugs after the patent expires, which has also promoted the rapid development of generic drugs in India.
The convenience of online drug purchases
With the development of the Internet, it has become increasingly convenient to purchase Indian generic drugs through cross-border e-commerce platforms. Many patients purchase Indian drugs through online channels, which saves time and reduces purchase costs. This convenient way of purchasing drugs makes Indian generic drugs highly competitive in the Chinese market.
Social cognition and word-of-mouth effect
The awareness and acceptance of Indian generic drugs in China has gradually increased, partly due to the promotion of some film and television works and news reports. For example, the promotion of Indian generic drugs in the movie "Dying to Survive" has enabled the public to have a deeper understanding and trust in them. In addition, the use experience and word-of-mouth communication of some patients have also promoted the popularization of Indian generic drugs in China.
Conclusion
In summary, the phenomenon of buying Indian generic drugs in China is the result of the combined effect of multiple factors. Price advantages, drug quality, supply and demand contradictions, policy environment, the convenience of online drug purchases, and social cognition make Indian generic drugs more attractive in the Chinese market. As China's medical reform deepens, there may be more policies to support the development of domestic generic drugs in the future, but at this stage, Indian generic drugs will still meet the medical needs of Chinese patients to a certain extent.